Supraphysiological Testosterone Therapy as Treatment for Castration-Resistant Prostate Cancer

por Lam, Hung-Ming, Corey, Eva
Publicado 2018

Proteomic and Transcriptomic Profiling Reveals Mitochondrial Oxidative Phosphorylation as Therapeutic Vulnerability in Androgen Receptor Pathway Active Prostate Tumors

por Xue, Caroline, Corey, Eva, Gujral, Taranjit S.
Publicado 2022

A ribonucleoprotein octamer for targeted siRNA delivery

por Tai, Wanyi, Li, Junwei, Corey, Eva, Gao, Xiaohu
Publicado 2018

Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment

por Brubaker, Kristen D, Brown, Lisha G, Vessella, Robert L, Corey, Eva
Publicado 2006

Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer

por Montgomery, Bruce, Nelson, Peter S, Vessella, Robert, Kalhorn, Tom, Hess, David, Corey , Eva
Publicado 2010

Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastases

por Morrissey, Colm, Kostenuik, Paul L, Brown, Lisha G, Vessella, Robert L, Corey, Eva
Publicado 2007

Lineage relationship between prostate adenocarcinoma and small cell carcinoma

por Kanan, Adelle D., Corey, Eva, Vêncio, Ricardo Z. N., Ishwar, Arjun, Liu, Alvin Y.
Publicado 2019

Data of relative mRNA and protein abundances of androgen receptor splice variants in castration-resistant prostate cancer

por Ma, Tianfang, Ungerleider, Nathan, Zhang, Derek Y., Corey, Eva, Flemington, Erik K., Dong, Yan
Publicado 2021

Oxidation of p-[(125)I]Iodobenzoic Acid and p-[(211)At]Astatobenzoic Acid Derivatives and Evaluation In Vivo

por Li, Yawen, Chyan, Ming-Kuan, Hamlin, Donald K., Nguyen, Holly, Corey, Eva, Wilbur, D. Scott
Publicado 2022

Inhibition of CCL2 Signaling in Combination with Docetaxel Treatment Has Profound Inhibitory Effects on Prostate Cancer Growth in Bone

por Kirk, Peter S., Koreckij, Theodore, Nguyen, Holly M., Brown, Lisha G., Snyder, Linda A., Vessella, Robert L., Corey, Eva
Publicado 2013

Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and Questions

por Mohammad, Osama S., Nyquist, Michael D., Schweizer, Michael T., Balk, Stephen P., Corey, Eva, Plymate, Stephen, Nelson, Peter S., Mostaghel, Elahe A.
Publicado 2017

Androgen Deprivation Leads to Increased Carbohydrate Metabolism and Hexokinase 2 Mediated Survival in Pten/Tp53 Deficient Prostate Cancer

por Martin, Philip L., Yin, Juan-Juan, Seng, Victoria, Casey, Orla, Corey, Eva, Morrissey, Colm, Simpson, R. Mark, Kelly, Kathleen
Publicado 2016

Androgen Receptor-Induced Integrin α6β1 and Bnip3 Promotes Survival and Resistance to PI3K Inhibitors in Castration-Resistant Prostate Cancer

por Nollet, Eric A., Cardo-Vila, Marina, Ganguly, Sourik S., Tran, Jack D., Schulz, Veronique V., Cress, Anne, Corey, Eva, Miranti, Cindy K.
Publicado 2020

Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature

por Labrecque, Mark P., Brown, Lisha G., Coleman, Ilsa M., Nguyen, Holly M., Lin, Daniel W., Corey, Eva, Nelson, Peter S., Morrissey, Colm
Publicado 2021

Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR Signaling

por Zhang, Xiong, Huang, Zenghong, Wang, Junjian, Ma, Zhao, Yang, Joy, Corey, Eva, Evans, Christopher P., Yu, Ai-Ming, Chen, Hong-Wu
Publicado 2021

Altered glucuronidation deregulates androgen dependent response profiles and signifies castration resistance in prostate cancer

por Zimmer, Brenna M., Howell, Michelle E., Ma, Linlin, Enders, Jeffrey R., Lehman, Danielle, Corey, Eva, Barycki, Joseph J., Simpson, Melanie A.
Publicado 2021

Rapid modification of the bone microenvironment following short-term treatment with Cabozantinib in vivo

por Haider, Marie-Therese, Hunter, Keith D., Robinson, Simon P., Graham, Timothy J., Corey, Eva, Dear, T. Neil, Hughes, Russell, Brown, Nicola J., Holen, Ingunn
Publicado 2015

Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate Cancer

por Watson, R. William, Azam, Haleema, Aura, Claudia, Russell, Niamh, McCormack, Janet, Corey, Eva, Morrissey, Colm, Crown, John, Gallagher, William M, Prencipe, Maria
Publicado 2020

Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate Cancer

por Coleman, Ilsa M., DeSarkar, Navonil, Morrissey, Colm, Xin, Li, Roudier, Martine P., Sayar, Erolcan, Li, Dapei, Corey, Eva, Haffner, Michael C., Nelson, Peter S.
Publicado 2022

IL1β Expression Driven by Androgen Receptor Absence or Inactivation Promotes Prostate Cancer Bone Metastasis

por DiNatale, Anthony, Worrede, Asurayya, Iqbal, Waleed, Marchioli, Michael, Toth, Allison, Sjöström, Martin, Zhu, Xiaolin, Corey, Eva, Feng, Felix Y., Zhou, Wanding, Fatatis, Alessandro
Publicado 2022